Procurement of biothrax
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- W911SR24D0001
- Awardee
-
Emergent Biodefense Operations Lansing LLC UEI MUM1EGCDWZJ4
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Task orders
- 2 $63,335,808 obligated
Award facts
- Combined order value
-
- $63,335,808 Current, with exercised options
- $108,683,808 Potential, with all options
- Last date to order 29% complete
- IDV ceiling 27% used
- $235,800,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this IDV
The Joint PEO Chemical and Biological Defense (Department of the Army Acquisition Support Center) awarded a single-award indefinite delivery contract to Emergent Biodefense Operations Lansing LLC on January 9, 2024, for procurement of BioThrax (anthrax vaccine adsorbed), with a ceiling value of $235.8 million and ultimate completion date of September 30, 2033. This is a no-set-aside procurement. BioThrax is the only FDA-licensed vaccine for anthrax prevention and serves as a critical component of the U.S. government's strategic national stockpile.
Place of performance is Lansing, Michigan. Work falls under NAICS 325414 (Biological Product Manufacturing) and PSC 6505 (Drugs and Biologicals).
Recent delivery orders issued under this IDIQ include a $66.9 million order awarded January 4, 2026, for completion by September 30, 2029, and a $41.8 million order awarded January 22, 2024, for completion by September 30, 2025. Both orders are firm fixed-price and carry no set-aside designation.
Emergent Biodefense is a self-certified small disadvantaged business headquartered in Lansing, Michigan, and serves as the manufacturer of BioThrax for the federal government.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| For the procurement of biothrax (anthrax vaccine absorbed (AVA)) | ACC Aberdeen Proving Ground | $21,534,000 | |
| Procurement of biothrax (anthrax vaccine adsorbed) | ACC Aberdeen Proving Ground | $41,801,810 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W911SR24D0001?
W911SR24D0001 was awarded to Emergent Biodefense Operations Lansing LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on January 9, 2024.
How much is contract W911SR24D0001 worth?
Orders under W911SR24D0001 have obligated $63,335,808. Their combined potential value, with all options, is $108,683,808. W911SR24D0001's own ceiling is $235,800,000.
How many orders have been placed under contract W911SR24D0001?
2 orders have been placed under W911SR24D0001, the latest on January 4, 2026.
Which agency awarded contract W911SR24D0001?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR24D0001, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Who can order from contract W911SR24D0001?
W911SR24D0001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W911SR24D0001 competed?
The extent of competition for W911SR24D0001 was not available for competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV